Bartlett & Co. LLC Bristol Myers Squibb CO Transaction History

Bartlett & Co. LLC

$6.16 Billion
Q4 2023

A detailed history of Bartlett & Co. LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bartlett & Co. LLC holds 280,510 shares of BMY stock, worth $14.9 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

280,510

Previous 379,813 26.15%

Holding current value

$14.9 Million

Previous $22 Million 34.82%

% of portfolio

0.23%

Previous 0.4%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	SELL	$48.48 - $57.85 $4.81 Million - $5.74 Million	-99,303 Reduced 26.15%	280,510 $14.4 Million
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $12.2 Million - $13.6 Million	-210,231 Reduced 35.63%	379,813 $22 Million
Q2 2023 Jul 14, 2023	SELL	$63.71 - $70.74 $17.2 Million - $19.1 Million	-270,369 Reduced 31.42%	590,044 $37.7 Million
Q1 2023 Apr 06, 2023	BUY	$65.71 - $74.53 $465,358 - $527,821	7,082 Added 0.83%	860,413 $59.6 Million
Q4 2022 Jan 04, 2023	BUY	$68.48 - $81.09 $205,713 - $243,594	3,004 Added 0.35%	853,331 $61.4 Million
Q3 2022 Oct 17, 2022	BUY	$0.13 - $76.84 $759 - $448,668	5,839 Added 0.69%	850,327 $60.5 Million
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $812,617 - $894,976	-11,190 Reduced 1.31%	844,488 $65.5 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $1.49 Million - $1.79 Million	24,291 Added 2.92%	855,678 $62.9 Million
Q4 2021 Mar 08, 2022	SELL	$53.63 - $62.52 $2.65 Million - $3.09 Million	-49,373 Reduced 5.61%	831,387 $51.8 Million
Q3 2021 Oct 15, 2021	BUY	$59.17 - $69.31 $811,575 - $950,655	13,716 Added 1.58%	880,760 $52.1 Million
Q2 2021 Jul 19, 2021	BUY	$61.91 - $67.42 $167,961 - $182,910	2,713 Added 0.31%	867,044 $57.9 Million
Q1 2021 Apr 19, 2021	BUY	$59.34 - $66.74 $2.21 Million - $2.49 Million	37,236 Added 4.5%	864,331 $54.6 Million
Q4 2020 Jan 20, 2021	BUY	$57.74 - $65.43 $102,315 - $115,941	1,772 Added 0.21%	827,095 $51.3 Million
Q3 2020 Oct 20, 2020	BUY	$57.43 - $63.64 $2.28 Million - $2.53 Million	39,679 Added 5.05%	825,323 $49.8 Million
Q2 2020 Aug 03, 2020	BUY	$54.82 - $64.09 $3.23 Million - $3.78 Million	59,007 Added 8.12%	785,644 $46.2 Million
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $2.79 Million - $4.06 Million	60,191 Added 9.03%	726,637 $40.5 Million
Q3 2019 Nov 04, 2019	BUY	$42.77 - $50.71 $7.19 Million - $8.53 Million	168,185 Added 33.75%	666,446 $33.8 Million
Q2 2019 Jul 24, 2019	BUY	$44.62 - $49.34 $6,157 - $6,808	138 Added 0.03%	498,261 $22.6 Million
Q1 2019 Apr 23, 2019	BUY	$45.12 - $53.8 $2.64 Million - $3.15 Million	58,482 Added 13.3%	498,123 $0
Q4 2018 Jan 23, 2019	SELL	$48.76 - $63.23 $2.33 Million - $3.03 Million	-47,862 Reduced 9.82%	439,641 $22.9 Million
Q3 2018 Oct 15, 2018	BUY	$55.19 - $62.25 $44,041 - $49,675	798 Added 0.16%	487,503 $30.3 Million
Q2 2018 Jul 31, 2018	SELL	$50.53 - $62.98 $2.19 Million - $2.73 Million	-43,319 Reduced 8.17%	486,705 $26.9 Million
Q1 2018 Apr 25, 2018	BUY	$59.92 - $68.98 $241,297 - $277,782	4,027 Added 0.77%	530,024 $33.5 Million
Q4 2017 Jan 19, 2018	SELL	$59.94 - $65.35 $1.06 Million - $1.16 Million	-17,747 Reduced 3.26%	525,997 $32.2 Million
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $30 Million - $34.7 Million	543,744	543,744 $34.7 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.

Account